Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1583-1590

  Fujieda, Shigeharu ^a   Sunaga, Hiroshi ^a   Tsuzuki, Hideaki ^a   Tanaka, Nobuyuki ^a   Saito, Hitoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; THROMBOCYTE; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; OROPHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; THYMIDINE PHOSPHORYLASE; TIME FACTORS;

EID: 0031744482     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Folkman, J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res., 46: 467-473, 1986.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
3. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
4. Horak, E. R., Leek, R., Klenk, N., Lejeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K., and Harris, A. L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 340: 1120-1124, 1992.
5. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
6. Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F., and Angeletti, C. A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet, 340: 145-146, 1992.
7. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401-409, 1993.
8. Hollingsworth, H. C., Kohn, E. C., Steinberg, S. M., Rothenberg, M. L., and Merino, M. J. Tumor angiogenesis in advanced stage ovarian carcinoma. Am. J. Pathol., 147: 33-41, 1995.
9. Maeda, K., Chung, Y-S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., Arimoto, Y., Kondo, Y., and Sawa, M. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. Clin. Oncol., 13: 477-481, 1995.
10. Tanigawa, N., Amaya, H., Matsumura, M., Shimomatsuya, T., Horiuchi, T., Muraoka, R., and Iki, M. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinoma. Cancer Res., 56: 2671-2676, 1996.
11. Tanigawa, N., Amaya, H., Matsumura, M., and Shimomatsuya, T. Association of tumour vasculature with tumour progression and overall survival of patients with non-early gastric carcinoma. Br. J. Cancer, 75: 566-571, 1997.
12. Tanigawa, N., Amaya, H., Matsumura, M., Lu, C., Kitaoka, A., Matsuyama, K., and Muraoka, R. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res., 57: 1043-1046, 1997.
13. Tanigawa, N., Matsumura, M., Amaya, H., Kitaoka, A., Shimomatsuya, T., Lu, C., Muraoka, R., and Tanaka, T. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer (Phila.), 79: 220-225, 1997.
14. Miyazono, K., Okabe, T., Urabe, A., Takaku, F., and Heldin, C-H. Purification and properties of an endothelial cell growth factor from human platelets. J. Biol. Chem., 262: 4098-4103, 1987.
15. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C-H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.), 338: 557-562, 1989.
16. Haraguchi, M., Miyadera, K., Uemura, K., Sumizawa, T., Furukawa, T., Yamada, K., and Akiyama, S-I. Angiogenic activity of enzymes. Nature (Lond.), 368: 198, 1994.
17. Moghaddam, A., Zhang, H-T., Fan, T-P. D., Hu, D-E., Lees, V. C., Turley, H., Fox, S. B., Catter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenetic and promotes tumor growth. Proc. Natl. Acad. Sci. USA, 92: 998-1002, 1995.
18. Miyadera, K., Sumizawa, T., Haraguchi, M., Yoshida, H., Konstanty, W., Yamada, Y., and Akiyama, S-I. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res., 55: 1687-1690, 1995.
19. Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H., and Tominaga, T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer, 64: 79-82, 1995.
20. Toi, M., Inada, K., Hoshina, S., Suzuki, H., Kondo, S., and Tominaga, T. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin. Cancer Res., 1: 961-964, 1995.
21. Takebayashi, Y., Akiyama, S-I., Akiba, S., Yamada, K., Miyadera, K., Sumizawa, T., Yamada, Y., Murata, F., and Aikou, T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst., 88: 1110-1107, 1996.
22. Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., Bicknell, R., Gatter, K. C., and Harris, A. L. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer, 73: 275-280, 1996.
23. O'Brien, T. S., Fox, S. B., Dickinson, A. J., Turley, H., Westwood, M., Moghaddam, A., Gatter, K. C., Bicknell, R., and Harris, A. L. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res., 56: 4799-4804, 1996.
24. Maeda, K., Chung, Y-S., Ogawa, Y., Takatsuka, S., Kang, S-M., Ogawa, M., Sawada, T., Onoda, N., Kato, Y., and Sowa, M. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br. J. Cancer, 73: 884-888, 1996.
25. Usuki, K., Saras, J., Waltenberger, J., Miyazono, K., Pierce, G., Thomason, A., and Heldin, C-H. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem. Biophys. Res. Commun., 184: 1311-1316, 1992.
26. Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M., Akiyama, S-I., Fukui, K., Ishizawa, M., and Yamada, Y. Angiogenic factor. Nature (Lond.), 356: 668, 1992.
27. Yoshimura, A., Kumazuru, Y., Furukawa, T., Yoshida, H., Yamada, K., and Akiyama, S-I. Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta, 1034: 107-113, 1990.
28. Luccioni, C., Beaumatin, J., Bardot, V., and Lefranqois, D. Pyrimidine nucleotide metabolism in human colon carcinoma: comparison of normal tissues, primary tumors and xenografts. Int. J. Cancer, 58: 517-522, 1994.
29. Fujimoto, S., Wang, Y., Inoue, K., and Ogawa, M. Antitumor activity of a new fluoropyrimidine derivative, 5′-deoxy-5-fluorouridine, against murine and human experimental tumors. Jpn. J. Cancer Res., 76: 644-650, 1985.
30. Birnie, G. D., Kroeger, H., and Heidelberger, C. Studies of fluoronated pyrimidines. VIII. The degradation of 5-fluoro-2′-deoxy-uridine and related compounds by nucleoside phosphorylase. Biochemistry, 2: 566-572, 1963.
31. Haraguchi, M., Furukawa, T., Sumizawa, T., and Akiyama, S-I. Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res., 53: 5680-5682, 1993.
32. Patterson, A. V., Zhang, H., Moghaddam, A., Bicknell, R., Talbot, D. C., Stratford, I. J., and Harris, A. L. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br. J. Cancer, 72: 669-675, 1995.
33. Kato, Y., Matsukawa, S., Muraoka, R., and Tanigawa, N. Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA. Br. J. Cancer, 75: 506-511, 1997.
34. Jacobs, C., Lyman, G., Velez-Garcia, E., Sridhar, K. S., Knight, W., Hochster, H., Goodnough, L. T., Mortimer, J. E., Einhorn, L. H., Schacter, L., Cherng, N., Dalton, T., Burroughs, J., and Rozencweig, M. A phase ni randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J. Clin. Oncol., 10: 257-263, 1992.
35. Tsuzuki, H., Fujieda, S., Sunaga, H., Ichiro, N., and Saito, H. Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma. Cancer Res., 58: 794-800, 1998.
36. Fox, S. B., Moghaddam, A., Westwood, M., Turley, H., Bicknell, R., Gatter, K. C., and Harris, A. L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J. Pathol., 176: 183-190, 1995.
37. Schlingemann, R. O., Rietveld, F. J. R., De-Waal, R. M. W., Bradley, N. J., Skene, A. I., Davies, A. J. S., Greaves, M. F., Denekamp, J., and Ruiter, D. J. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab. Invest., 62: 690-696, 1990.
38. Fujieda, S., Noda, I., Saito, H., Hoshino, T., and Yagita, M. Swainsonine augments the cytotoxicity of human lymphokine-activated killer cells against autologous thyroid cancer cells. Arch. Otolaryngol. Head Neck Surg., 120: 389-394, 1994.
39. Fujieda, S., Noda, I., Saito, H., Hoshino, T., and Yagita, M. Heat shock enhances the susceptibility of tumor cells to lysis by lymphokine-activated killer cells. Arch. Otolaryngol. Head Neck Surg., 121: 1009-1014, 1995.
40. Garewal, H. S., Ahmann, F. R., Schifman, R. B., and Celniker, A. ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects. J. Natl. Cancer Inst., 77: 1039-1045, 1986.
41. Koechli, O. R., Sevin, B-U., Perras, J. P., Angioli, R., Untch, M., Steren, A., Ramachandran, C., and Averette, H. E. Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assay. Oncology, 51: 552-558, 1994.
42. Andreotti, P. E., Cree, L. A., Kurbacher, C. M., Hartmann, D. M., Linder, D., Harel, G., Gleiberman, I., Caruso, P. A., Ricks, S. H., Untch, M., Sartori, C., and Bruckner, H. W. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res., 55: 5276-5282, 1995.
43. Griffiths, L., Dachs, G. U., Bicknell, R., Harris, A. L., and Stratford, I. J. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells growth in vitro and in vivo. Cancer Res., 57: 570-572, 1997.
44. Dachs, G. U., and Stratford, I. J. The molecular response of mammalian cells to hypoxia and potential for exploitation in cancer therapy. Br. J. Cancer, 74: S126-S132, 1996.
45. Griffiths, J. R. Are cancer cells acidic? Br. J. Cancer, 64: 425-427, 1991.
46. Kraus, M., Severian, T., and Wolf, B. Relevance of microenvironmental pH for self-organized tumor growth and invasion. Anticancer Res., 14: 1573-1584, 1994.
47. Gatenby, R. A., and Gawlinski, E. T. A reaction-diffusion model of cancer invasion. Cancer Res., 56: 5745-5753, 1996.
48. Kato, Y., Nakayama, Y., Umeda, M., and Miyazaki, K. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J. Biol. Chem., 267: 11424-11430, 1992.
49. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
50. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer. Cancer Res., 57: 136-140, 1997.
51. Relf, M., LeJeune, S., Scott, P. A. E., Fox, S. B., Smith, K., Leek, R., Moghaddam, A., Whitehouse, R., Bicknell, R., and Harris, A. L. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res., 57: 963-969, 1997.
52. Fang, W., Hartmann, N., Chow, D. T., Riegel, A. T., and Wellstein, A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J. Biol. Chem., 267: 25889-25897, 1992.
53. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, M. Macrophages and angiogenesis. J. Leukocyte Biol., 55: 410-422, 1994.
54. Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993.
55. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
56. Schwartz, E. L., Baptiste, N., Wadler, S., and Makower, D. Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J. Biol. Chem., 270: 19073-19077, 1995.
57. Johnston, P. G., Lenz, H-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
58. Brown, E., and Markman, M. Tumor chemosensitivity and chemoresistance assays. Cancer (Phila.), 77: 1020-1025, 1996.
59. Saito, H., Otsubo, T., Fujieda, S., and Tanigawa, N. Chemosensitivity of head and neck cancer with the rapid thymidine incorporation assay and its clinical application. Eur. Arch. Otorhinolaryngol., 249: 400-403, 1992.